Doumith M, Legrand R, Lang C, Salas J A, Raynal M C
Infectious Disease Group, Hoechst Marion Roussel, Romainville, France.
Mol Microbiol. 1999 Dec;34(5):1039-48. doi: 10.1046/j.1365-2958.1999.01666.x.
Two glycosyltransferase genes, oleG1 and oleG2, and a putative isomerase gene, oleP1, have previously been identified in the oleandomycin biosynthetic gene cluster of Streptomyces antibioticus. In order to identify which of these two glycosyltransferases encodes the desosaminyltransferase and which the oleandrosyltransferase, interspecies complementation has been carried out, using two mutant strains of Saccharopolyspora erythraea, one strain carrying an internal deletion in the eryCIII (desosaminyltransferase) gene and the other an internal deletion in the eryBV (mycarosyltransferase) gene. Expression of the oleG1 gene in the eryCIII deletion mutant restored the production of erythromycin A (although at a low level), demonstrating that oleG1 encodes the desosaminyltransferase required for the biosynthesis of oleandomycin and indicating that, as in erythromycin biosynthesis, the neutral sugar is transferred before the aminosugar onto the macrocyclic ring. Significantly, when an intact oleG2 gene (presumed to encode the oleandrosyltransferase) was expressed in the eryBV deletion mutant, antibiotic activity was also restored and, in addition to erythromycin A, new bioactive compounds were produced with a good yield. The neutral sugar residue present in these compounds was identified as L-rhamnose attached at position C-3 of an erythronolide B or a 6-deoxyerythronolide B lactone ring, thus indicating a relaxed specificity of the oleandrosyltransferase, OleG2, for both the activated sugar and the macrolactone substrate. The oleP1 gene located immediately upstream of oleG1 was likewise introduced into an eryCII deletion mutant of Sac. erythraea, and production of erythromycin A was again restored, demonstrating that the function of OleP1 is identical to that of EryCII in the biosynthesis of dTDP-D-desosamine, which we have previously proposed to be a dTDP-4-keto-6-deoxy-D-glucose 3, 4-isomerase.
先前已在抗生链霉菌的竹桃霉素生物合成基因簇中鉴定出两个糖基转移酶基因oleG1和oleG2,以及一个假定的异构酶基因oleP1。为了确定这两种糖基转移酶中哪一种编码去氧氨基糖基转移酶,哪一种编码夹竹桃糖基转移酶,利用了红霉糖多孢菌的两种突变菌株进行种间互补,一种菌株在eryCIII(去氧氨基糖基转移酶)基因中存在内部缺失,另一种菌株在eryBV(霉糖基转移酶)基因中存在内部缺失。oleG1基因在eryCIII缺失突变体中的表达恢复了红霉素A的产生(尽管水平较低),这表明oleG1编码竹桃霉素生物合成所需的去氧氨基糖基转移酶,并表明,与红霉素生物合成一样,中性糖在氨基糖之前转移到大环上。值得注意的是,当完整的oleG2基因(假定编码夹竹桃糖基转移酶)在eryBV缺失突变体中表达时,抗生素活性也得到恢复,并且除了红霉素A之外,还以良好的产量产生了新的生物活性化合物。这些化合物中存在的中性糖残基被鉴定为连接在红霉内酯B或6-脱氧红霉内酯B内酯环的C-3位上的L-鼠李糖,因此表明夹竹桃糖基转移酶OleG2对活化糖和大环内酯底物的特异性较为宽松。同样位于oleG1紧邻上游的oleP1基因被导入红霉糖多孢菌的eryCII缺失突变体中,红霉素A的产生再次恢复,这表明OleP1在dTDP-D-去氧氨基糖生物合成中的功能与EryCII相同,我们先前曾提出EryCII是一种dTDP-4-酮-6-脱氧-D-葡萄糖3,4-异构酶。